Emergent BioSolutions Inc (NYSE: EBS) stock suffered a major decline of -11.1% on 9/3/24. The shares closed at $7.39. NORMAL trading volume accompanied the decline. The stock has been exceptionally strong relative to the market […]
On 9/3/24, Citizens Financial Services Inc (NASDAQ: CZFS) stock suffered a major decline of -10.0%, closing at $51.20. However, exceptionally low trading volume at 31% of normal accompanied the decline. The stock has declined -7.5% […]
Amkor Technology Inc (NASDAQ: AMKR) stock closed at $29.60 on 9/3/24 after a major decline of -10.0%. NORMAL trading volume accompanied the decline. The stock has declined -11.3% during the last week but has been […]
Synaptics Inc (NASDAQ: SYNA) stock closed at $72.83 on 9/3/24 after a major decline of -10.6%. Moreover, above average trading volume at 129% of normal accompanied the decline. The stock has declined -9.6% during the […]
On 9/3/24, Sterling Infrastructure Inc (NASDAQ: STRL) stock suffered a major decline of -10.4%, closing at $107.06. Moreover, this decline was accompanied by above average trading volume at 121% of normal. Relative to the market […]
On 9/3/24, Monolithic Power Systems Inc (NASDAQ: MPWR) stock suffered a major decline of -10.3%, closing at $838.63. Moreover, this decline was accompanied by unusually high trading volume at 170% of normal. Relative to the […]
On 9/3/24, Modine Manufacturing Co (NYSE: MOD) stock suffered a major decline of -10.9%, closing at $108.31. This decline was accompanied by normal trading volume. Relative to the market the stock has been exceptionally strong […]
XBiotech Inc (NASDAQ: XBIT) stock suffered a major decline of -10.2% on 9/3/24. The shares closed at $5.75. However, trading volume in this decline was exceptionally low at 49% of normal. Relative to the market […]
Perspective Therapeutics Inc (NYSEAMERICAN: CATX) stock closed at $14.18 on 9/3/24 after a major decline of -10.3%. NORMAL trading volume accompanied the decline. The stock has been exceptionally strong relative to the market over the […]
NovoCure Ltd (NASDAQ: NVCR) stock closed at $16.75 on 9/3/24 after a major decline of -13.8%. Moreover, exceptionally high trading volume at 204% of normal accompanied the decline. Relative to the market the stock has […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research